Ethics Committee Greenlights Clinical Trial of IHL-42X for Sleep Apnea

The clinical trial will assess the pharmacokinetics and tolerability of the two active pharmaceutical ingredients in IHL-42X: dronabinol (THC) and acetazolamide.